Showing results (1751-1760 of 1,768) with videos related to

Sort By:
Pageof 177
Cell Transplantation|April 30, 2025
Comparison of plasma sterilizer and conventional laminar flow room in allogeneic hematopoietic stem cell transplant recipientsTing Wang, Yi Xia, Wei Hu, et al.
Signal Transduction and Targeted Therapy|March 26, 2024
First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 studyXiaofeng Chen, Hao Xu, Xiaobing Chen, et al.
ACS Chemical Biology|April 17, 2012
A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosisPuiying A Mak, Srinivasa P S Rao, Mai Ping Tan, et al.
Vaccine|May 2, 2002
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccineRama Rao Amara, Francois Villinger, John D Altman, et al.
The Lancet Regional Health. Western Pacific|April 16, 2025
Twelve-month prevalence of DSM-5 mental disorders and the psychosocial correlates- a child and adolescent psychiatric epidemiologic survey in Hong Kong SARSandra S M Chan, Oscar W H Wong, Samara Hussain, et al.
Gut|June 30, 2026
Helicobacter pylori infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trialsXuan Han, Heng-Min Xu, Zong-Chao Liu, et al.
JAMA Network Open|May 29, 2024
Helicobacter pylori Treatment and Gastric Cancer Risk Among Individuals With High Genetic Risk for Gastric CancerHeng-Min Xu, Yuting Han, Zong-Chao Liu, et al.
Gynecologic Oncology|March 23, 2021
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2Gottfried E Konecny, Amit M Oza, Anna V Tinker, et al.
Gynecologic Oncology|September 9, 2017
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2Amit M Oza, Anna V Tinker, Ana Oaknin, et al.
Nature Medicine|July 30, 2024
Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trialKai-Feng Pan, Wen-Qing Li, Lian Zhang, et al.
Pageof 177